Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5774481

CCN(Cc1ccncc1)C(=O)CCc1cnoc1-c1ccc(F)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
LMNA P02545 3/20 0.42
TSHR P16473 3/20 0.42
HPGD P15428 1/20 0.42
ATM Q13315 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
RAB9A P51151 1/20 0.38
FNTA P49354 1/20 0.37
FNTB P49356 1/20 0.37
USP2 O75604 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM5 P08912 1/20 0.35
MAPT P10636 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5775660 0.85 HTR5A (0.47) ALDH1A1LMNATSHRHPGDATM
Trifluoroacetic Acid SCHEMBL5776953 0.84 PKM (0.48) ALDH1A1LMNATSHRNPSR1FNTA
SCHEMBL5771831 0.80 HDAC8 (0.34) CYP3A4
SCHEMBL5774168 0.80 ALDH1A1 (0.45) ALDH1A1LMNATSHRHPGDATM
SCHEMBL5774452 0.79 TSHR (0.44) ALDH1A1LMNATSHRHPGDATM
Trifluoroacetic Acid SCHEMBL5771828 0.79 GSK3B (0.42) ALDH1A1LMNATSHRHPGDCYP2C9
Trifluoroacetic Acid SCHEMBL5770496 0.79 HDAC4 (0.36) ALDH1A1TSHRRAB9ACYP2C19CYP1A2
Trifluoroacetic Acid SCHEMBL5770769 0.79 HTR5A (0.38) ALDH1A1LMNATSHRRAB9AKMT2A
Trifluoroacetic Acid SCHEMBL5773568 0.79 EPHX2 (0.52) HPGDCYP2C9CYP2C19MEN1KMT2A
Trifluoroacetic Acid SCHEMBL5771064 0.77 LMNA (0.44) LMNATSHRRAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR ALDH1A1 1045/4885LMNA 2770/4885TSHR 534/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 ALDH1A1 682/4885LMNA 2605/4885TSHR 583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.